Dr Latour-Perez's concerns[1] are anticipated on page 474 of our
article, which summarises the results of three good quality studies using
CTPA (not multi-slice) as the only imaging modality (references 187-189).
Just after going to press we became aware of a recent excellent large
multicentre study [2] with similar results. Combining these four of
similar design (well conducted, CTPA only, no anticoagul...
Dr Latour-Perez's concerns[1] are anticipated on page 474 of our
article, which summarises the results of three good quality studies using
CTPA (not multi-slice) as the only imaging modality (references 187-189).
Just after going to press we became aware of a recent excellent large
multicentre study [2] with similar results. Combining these four of
similar design (well conducted, CTPA only, no anticoagulation if PE
excluded), the PE rate at 3 months is only 0.9% (10/1100). So, even though
CTPA will miss some small PEs (also true of conventional pulmonary
angiography) this possibility needn't worry clinicians.
References
(1) Latour-Perez J. Anticoagulation in suspected pulmonary embolism and negative Computed Computed tomographic pulmonary [electonic response to BTS Guidelines: British Thoracic Society guidelines for the management of suspected acute pulmonary embolism] thoraxjnl.com 2003 http://thorax.bmjjournals.com/cgi/eletters/58/6/470#87
(2) Van Strijen MJ, et al. Single-detector helical computed
tomography as the primary diagnostic test in suspected pulmonary embolism:
a multicenter clinical management study of 510 patients. Ann Intern Med 2003;138:307-314.
I would like to express my concern about the recent British Thoracic
Society guidelines for the management of suspected acute pulmonary
embolism,[1] which suggest that “Patients with a good quality negative
CTPA do not require further investigation or treatment for PE.” [grade A
recommendation]:
1. According to a recent well designed study,[2] the negative
likelihood ratio of CTPA f...
I would like to express my concern about the recent British Thoracic
Society guidelines for the management of suspected acute pulmonary
embolism,[1] which suggest that “Patients with a good quality negative
CTPA do not require further investigation or treatment for PE.” [grade A
recommendation]:
1. According to a recent well designed study,[2] the negative
likelihood ratio of CTPA for the diagnosis of pulmonary embolism is about
0.33. If we assume a pre-test probability is 78% (Well’s high clinical
probability),[3] the probability of pulmonary embolism after a negative
CTPA is about 54%. This figure looks too high to suspend the anticoagulant
treatment.
2. The empirical evidence that supports the safety of withholding
anticoagulant treatment in patients with negative CTPA is of poor quality:
- Most of the studies (cohort restrospective studies), do not exclude
the possibility that the patients that were anticoagulated despite a
negative CTPA (and consequently excluded from the studies) were more prone
to recurrent thromboembolic events than patients in which anticoagulant
treatment was stopped.
- In some patients, the diagnostic workup included other diagnostic
tools to exclude deep venous thrombosis, besides CTPA.
- The magnitude of the loses to follow-up is often substantial, so we
cannot confidently exclude the occurrence of thromboembolic events in
these patients.
3. Probably the best evidence that supports the safety of stopping the
anticoagulation comes from the study of Swensen et al.[4], a retrospective
study based upon 1010 patients, with a low percent of loses to follow up
and a low prevalence of anticoagulated patients. However, this study is
based on a last generation multi-slice electron beam scanner, and its
results cannot be extrapolated to the typical clinical environment.
Taking these points altogether, I consider that there are sound
doubts about the safety of withholding anticoagulant treatment after
negative CTPA findings, at least in patients with a high clinical
probability of PE and with the usual radiologic environment. Probably,
these conclusions should be revised according the new technological
improvements.
References
(1) British Thoracic Society Standards of Care Committee Pulmonary
Embolism Guideline Development Group. British Thoracic Society guidelines
for the management of suspected acute pulmonary embolism. Thorax
2003;58:470–484
(2) Perrier A, Howarth N, Didier D, Loubeyre P, Unger PF, de
Moerloose P, Slosman D, Junod A, Bounameaux H. Performance of Helical
Computed Tomography in unselected outpatients with suspected pulmonary
embolism. Ann Intern Med 2001;135:88-97.
(3) Wells PS, Ginsberg JS, Anderson DR, et al. Use of a clinical
model for safe management of patients with suspected pulmonary embolism.
Ann Intern Med 1998;129:997–1005.
(4) Swensen SJ, Sheedy PF, Ryu JH et al. Outcomes after withholding
anticoagulation from patients with suspected acute pulmonary embolism and
negative computed tomographic findings: a cohort study. Mayo Clin Proc
2002;77:130-138.
We thank Dr Chan for his comments relating to the recently published
guidelines for the diagnosis and management of spontaneous
pneumothorces.[1] Dr Chan raises the contentious issue of estimation of
the size of a pneumothorax from a plain chest radiograph. We have
attempted to use a variation of the method of Axel based on the largest
distance from the chest wall to the pleural line and using the assum...
We thank Dr Chan for his comments relating to the recently published
guidelines for the diagnosis and management of spontaneous
pneumothorces.[1] Dr Chan raises the contentious issue of estimation of
the size of a pneumothorax from a plain chest radiograph. We have
attempted to use a variation of the method of Axel based on the largest
distance from the chest wall to the pleural line and using the assumption
that because volume of the lung and the hemi-thorax are roughly
proportional to the cube of their diameters, the volume of pneumothorax
can be estimated by measuring an average diameter of the lung and the
hemithorax, cubing these diameters and finding the ratios.[2]
As Dr Chan rightly points out this is not an exact science as the
lungs have a propensity not to maintain a constant shape when they
collapse. CT of thorax, when compared with plain radiograph, gives a more
accurate estimate of the volume of the pneumothorax. However, while CT may
be the only way to give an exact estimate of pneumothorax volume and
pattern of lung collapse, it is not often feasible in the emergency room.
The correlation co-efficient between CT and plain radiograph is 0.71,
p<_0.01.3 thus="thus" while="while" cxr="cxr" is="is" not="not" as="as" effective="effective" ct="ct" it="it" does="does" still="still" provide="provide" a="a" useful="useful" and="and" reasonably="reasonably" accurate="accurate" estimate="estimate" of="of" pneumothorax="pneumothorax" size="size" in="in" most="most" cases="cases" using="using" the="the" method="method" outlined="outlined" current="current" guidelines.="guidelines." we="we" suggest="suggest" that="that" guideline="guideline" an="an" improvement="improvement" on="on" _1993="_1993" guidelines="guidelines" which="which" tended="tended" to="to" underestimate="underestimate" potentially="potentially" importance="importance" pneumothorax.="pneumothorax." choosing="choosing" distance="distance" _2="_2" cms="cms" above="above" volume="volume" usually="usually" _50="_50" gives="gives" emergency="emergency" room="room" physician="physician" easy="easy" use="use" fairly="fairly" reliable="reliable" adhere="adhere" to.="to." has="has" been="been" shown="shown" secondary="secondary" pneumothoraces="pneumothoraces" this="this" are="are" unlikely="unlikely" respond="respond" simple="simple" aspiration="aspiration" will="will" hopefully="hopefully" guidance="guidance" patients="patients" treat="treat" with="with" intercostals="intercostals" tube="tube" drainage.4="drainage.4" supported="supported" by="by" evidence="evidence" now="now" clear="clear" unambiguous="unambiguous" guideline.="guideline." also="also" hope="hope" suggesting="suggesting" _="_" _2cms="_2cms" depth="depth" should="should" be="be" aspirated="aspirated" may="may" reduce="reduce" number="number" needle="needle" injuries="injuries" lung="lung" parenchyma="parenchyma" would="would" have="have" much="much" greater="greater" approximation="approximation" chest="chest" wall="wall" primary="primary" spontaneous="spontaneous" cm="cm" depth.="depth." p="p"/> As Dr Chan points out the American College of Chest Physicians have
suggested a different arbitrary system for estimating pneumothorax size
suggesting that ‘small’ pneumothoraces were defined by distances <3
cms from apex to cupula of lung and ‘large’ pneumothoraces had distances
> 3cms.[5] This seems to have been arbitrarily defined and we are not
provided with evidence to support these measurements. Several authors have
suggested different distances ranging from 1-4 cms on plain radiograph or
more complex equations depending on distances from the pleural line to
chest wall at three separate distances or even routine use of CT
incorporating even more complex mathematics.[6,7] Dr Chan comments on the
lack of evidence regarding CXR classification – we have completed an
analysis of the CXR appearances in spontaneous pneumothorax, relating them
to the various guidelines, and submitted it as an abstract for the winter
meeting of the British Thoracic Society. Bearing in mind that the
guidelines are primarily prepared for use by relatively inexperienced and
non-specialist junior medical staff, who often have to make management
decisions in the middle of the night, we would suggest that the BTS
guidelines have combined a fairly robust and accurate scientific approach
with an easy to interpret and implement guideline to estimate and treat
spontaneous pneumothoraces. Finally, we would again take the opportunity
to stress that no matter what the size of a pneumothorax, the decision as
to what constitutes appropriate treatment depends not just on the size of
a pneumothorax on a chest radiograph, but more importantly, on the
clinical status of the patient.
References
(1) Henry M, Arnold T, Harvey J. BTS guidelines for the management of
spontaneous pneumothorax. Thorax 2003; 58(Suppl 11):ii39-52.
(2) Axel L. A simple way to estimate the size of pneumothoraces.
Invest Radiol 1981;105:1147-1150.
(3) Engdahl O, Toft T, Boe J. Chest radiograph - a poor method for
determining the size of a pneumothorax. Chest 1993;103:26-29.
(4) Baumann MH, Strange C, Heffner JE, et al. Management of
spontaneous pneumothorax. An American College of Chest Physicians Delphi
Consensus Statement. Chest 2001; 119: 590-602.
(5) Archer GJ, Hamilton AAD, Upadhyag R, et al. Results of simple
aspiration of pneumothoraces. Br J Dis Chest 1985; 79:177-182.
(6) Collins CD, Lopez A, Mathie A, Wood V, Jackson JE, Roddie ME.
Quantification of Pneumothorax size on chest radiographs using
intrapleural distances: Regression analysis based on volume measurements
from helical CT. Am J Radiol 1995;165:1127-1130.
"It is not the strongest of the species that survives, nor the most
intelligent, it is the one most adaptable to change." Charles Darwin (1809-1882)
The article "BTS guidelines for the management of spontaneous
pneumothorax" by Henry et al.[1] has recently stimulated some discussion
among our respiratory physicians and thoracic surgeons.
"It is not the strongest of the species that survives, nor the most
intelligent, it is the one most adaptable to change." Charles Darwin (1809-1882)
The article "BTS guidelines for the management of spontaneous
pneumothorax" by Henry et al.[1] has recently stimulated some discussion
among our respiratory physicians and thoracic surgeons.
We found it interesting that the authors quoted the recurrence rates
of pneumothorax after VATS (Video Assisted Thoracic Surgery) to be between
5-10%. Recently, numerous large series from around the world have shown
recurrence rates of primary spontaneous pneumothorax after VATS bullectomy
combined with surgical pleurodesis, to be in the range of 1.7-5.7%. [2,3]
Although the recurrence rates from VATS may be marginally higher than open
procedure, nevertheless, the benefit to the patient of shorter
postoperative hospital stay, less post-operative pain and better pulmonary
gas exchange in the postoperative period should be balanced. Furthermore,
we found in a study patients undergoing VATS to have significantly less
shoulder dysfunction and pain medication requirements in the early post-
operative period when compared with posterolateral thoracotomy.[4] Whether
VATS can be “established as being superior to thoracotomy” will in part be
decided by our patients and become clearer with future trials.
With the lowered morbidity and proven safety of VATS, even for
elderly and paediatric population,[2] the old surgical algorithms
developed based on the morbidity of thoracotomy should be re-evaluated.[5]
We feel there are two additional conditions that warrant inclusion in the
list for “accepted indication for operative intervention”. Firstly,
patients presenting with the life-threatening condition of tension
pneumothorax, even for the first time, should be considered for VATS
because of the potential grave consequences of its recurrence. Secondly,
presence of radiologically demonstrated huge bulla associated with
spontaneous pneumothorax should be an indication for VATS because of
increase risk of pneumothorax recurrence. In addition, the huge bulla may
continue to expand and impair lung function by causing compression of
adjacent healthy lung tissue, and can be manifestation of lung carcinoma
or a focus for recurrent infection.[2,6]
References
(1) M Henry, T Arnold and J Harvey. BTS guidelines for the management
of spontaneous pneumothorax. Thorax 2003;58:ii39
(2) Ng CSH, Wan S, Lee TW, Wan IYP, Arifi A, Yim APC. Video-assisted
thoracic surgery in spontaneous pneumothorax. Canadian Resp J 2002;9:122-
127.
(3) Yim APC, Ng CSH. Thoracoscopic management of spontaneous pneumothorax.
Curr Opin Pulm Med 2001;7:210-4.
(4) Li WWL, Lee RLM, Lee TW, Ng CSH, Sihoe ADL, Wan IYP, Arifi AA, Yim
APC. The impact of thoracic surgical access on early shoulder function:
video-assisted thoracic surgery versus posterolateral thoracotomy. Eur J
Cardiothorac Surg 2003;23:390-6
(5) Yim APC. Video assisted thoracoscopic surgery (VATS) in Asia: Its
impact and implications. Aust NZ J Med 1997;27:156-9
(6) Ng CSH, Sihoe ADL, Wan S, Lee TW, Arifi AA, Yim APC. Giant pulmonary
bulla. Can Respir J 2001;8:369-71
The BTS guideline on chest drain management unfortunately fails to
recognise the severity of illness of patients who generally require chest
drain insertion on an intensive care unit. In our practice chest drainage
for pleural effusions only occurs in ventilated patients who require more
than 5cm H20 PEEP and still have significantly impaired oxygenation
limiting their ability to be weaned fr...
The BTS guideline on chest drain management unfortunately fails to
recognise the severity of illness of patients who generally require chest
drain insertion on an intensive care unit. In our practice chest drainage
for pleural effusions only occurs in ventilated patients who require more
than 5cm H20 PEEP and still have significantly impaired oxygenation
limiting their ability to be weaned from ventilation. In this population
of patients portable ultrasound guidance is used routinely to reduce the
risk of damaging underlying lung but the ventilator is not disconnected as
lung recruitment will be lost and hypoxia will rapidly develop.
The negative findings of Joos et al. can be explained by the small
signal for bronchodilator reversibility,such that one would not expect to
detect any putative differences in beta-agonist response between
genotypes ,as compared to asthma where the signal is much bigger. With
repect to bronchial hyperresponsiveness (BHR), we have previously shown in
asthmatics ,that the glycine genotype is associ...
The negative findings of Joos et al. can be explained by the small
signal for bronchodilator reversibility,such that one would not expect to
detect any putative differences in beta-agonist response between
genotypes ,as compared to asthma where the signal is much bigger. With
repect to bronchial hyperresponsiveness (BHR), we have previously shown in
asthmatics ,that the glycine genotype is associated with enhanced BHR to
either direct (methacholine) or indirect (adenosine monophosphate) stimuli
,as compared to the arginine genotype.[1] Moreover the difference in BHR
was disconnected from airway caliber(as FEV1 and FEF25-75)or inhaled
steroid dose ,which did not differ between genotypes.Thus it may not be
possible to extrapolate from the effects of beta-2-receptor genotype in
asthma to what happens in COPD,where influences of altered airway geometry
are more important.
Reference
(1) Fowler SJ, Dempsey OJ, Sims EJ, Lipworth BJ. Screening for
bronchial hyperresponsiveness using methacholine and adenosine
monophosphate: relationship to asthma severity and beta-2-receptor
genotype.Am J Respir Crit Care Med 2000;162: 1318-1322.
I read with interest the latest comprehensive BTS guidelines on chest
drain insertion. We would like to share with you some tips and words of
caution accumulated by experience from our institute.
During chest drain insertion, we routinely monitor oxygen saturation
continuously with or without prior sedation. Patient with secondary
pneumothorax i.e. from COAD can deteriorate during chest drai...
I read with interest the latest comprehensive BTS guidelines on chest
drain insertion. We would like to share with you some tips and words of
caution accumulated by experience from our institute.
During chest drain insertion, we routinely monitor oxygen saturation
continuously with or without prior sedation. Patient with secondary
pneumothorax i.e. from COAD can deteriorate during chest drain insertion.
Furthermore, at the start of the procedure, the nasal oxygen cannula is
sited ( but not necessarily turned on) to allow quick delivery of oxygen
in an emergency situation. This is particularly true when patients are put
in the lateral decubitus position because placing nasal cannula may be
more difficult than if the patient is sitting.
In the section on drain removal, as a reminder to junior doctors, it
is generally recommended that the suction should be turned off prior to
removing the drain because of the theoretical risk of tearing the lung.
Interestingly, there is currently no strong evidence to support
removal of chest drains during the Valsalva manoeuvre or expiration; even
though the majority of doctors follow this guideline. Physiological
understanding suggest that creating a positive intrapleural pressure
during chest drain removal may reduce the risk of air entering the pleural
cavity. However, study by Bell et al. found no difference in pneumothorax
rate whether removal was performed at end inspiration or end
expiration.[1] Our experience suggest that important factors influencing
post-removal pneumothorax rate are:
(a) speed of chest drain removal to
prevent air entering the pleural cavity through the side holes at removal,
and (b) preventing para-drain leakage by digital compression of wound site
during removal.
Finally, we have experience of the drain kinking at the point where
the tube penetrates the chest wall. The "omental tag of tape" referred by
the guidelines can help reduce this occurence. In addition, we found it
useful to roll up 2-3 pieces of gauze and place it under (rather than
over) the drain right at the point where the tube penetrates the chest
wall to bolster the tube and prevent the acute angle it can form with the
chest wall, especially with over zealous or tight dressings at that area.
Reference
(1) Bell RL, Ovadia P, Abdullah F, Spector S, Rabinovici R. Chest
tube removal: end-inspiration or end-expiration?
J Trauma 2001;50:674-7.
I read, with interest, the new BTS guidelines for the management of
spontaneous pneumothorax.[1] Arnold and colleagues acknowledged that the
plain radiograph was a poor method of quantifying the size of a
pneumothorax, yet then went on to use one radiographic method of
assessment to estimate the degree of lung collapse.
Under the new guidelines, the size of a pneumothorax is divided into
"...
I read, with interest, the new BTS guidelines for the management of
spontaneous pneumothorax.[1] Arnold and colleagues acknowledged that the
plain radiograph was a poor method of quantifying the size of a
pneumothorax, yet then went on to use one radiographic method of
assessment to estimate the degree of lung collapse.
Under the new guidelines, the size of a pneumothorax is divided into
"small" or "large" depending on the presence of a visible rim of "<
2cm" or "> or = 2cm" between the lung margin and the chest wall. The
authors then explained in detail how these distances could be used to
estimate the percentage of lung collapse. A schematic figure was even used
to illustrate the calculations. However, the method employed by the
authors (the method of Axel),[2] like most other methods, have been shown
to be a poor method for determining pneumothorax size under clinical
conditions.[3]
I do not see any evidence that the new classification is in any way
better than the old one. The calculations based on the distance of the rim
correlated poorly to the actual size of pneumothorax.[3] The "2 cm" used
is an arbitrary figure. It is even more confusing to have the American
guidelines use another arbitrary system of classification.[4] In
spontaneous pneumothorax, practitioners should at least agree on the same
classification system of size before they continue to debate about what is
the best option of treatment.
References
(1) Henry M, Arnold T, Harvey J, et al. BTS guidelines for the
management of spontaneous pneumothorax. Thorax 2003;58(Suppl II):ii39-ii52.
(2) Axwl L. A simple way to estimate the size of a pneumothorax. Invest Radiol 1981;16:165-166.
(3) Engdahl O, Toft T, Boe J. Chest radiograph - a poor method for
determining the size of a pneumothorax. Chest 1993;103:26-29.
(4) Baumann MH, Strange C, Heffner JE, et al. Management of
spontaneous pneumothorax: an American College of Chest Physicians Delphi
Consensus Statement. Chest 2001;119:590-602
These clinically important papers [1,2] by the Isolde researchers
provide excellent data questioning the rationale behind inclusion of
patients in the large COPD-studies that have been reported in past few
years. Selection of patients on the basis of absence of reversibility
means ruling out the easiest measurable variable that may correlate with
steroid response. When assessing effects of two weeks pred...
These clinically important papers [1,2] by the Isolde researchers
provide excellent data questioning the rationale behind inclusion of
patients in the large COPD-studies that have been reported in past few
years. Selection of patients on the basis of absence of reversibility
means ruling out the easiest measurable variable that may correlate with
steroid response. When assessing effects of two weeks prednisolone, or the
value of reversibility as a determinant of long-term treatment response to
inhaled steroids, one should bear in mind that the Isolde population does
not represent the typical patient with COPD that primary care physicians
encounter in daily practice. In primary care, one finds all degrees of
reversibility, both mild, moderate and indeed some severe COPD, some with
and some without significant response. Although highly relevant, the
results of the two Isolde papers represent only moderate to severe COPD in
absence of reversibility. Therefore, Gross is very right in his editorial
to state that we should be openminded about the future; the COOPT-Study
which is currently conducted in the Netherlands (Europe) consciously
dismissed reversibility as an entry criterion and recruited its population
in primary care.[3] Similar to Isolde we performed the two weeks'
pretreatment with prednisolone before randomisation and will look at
reversibility as a determinant for inhaled steroid response. Results will
be available next year, and then we can finally widen our focus to include
the field of primary care as well. Don't worry about the fat lady; she
will be back.
References
(1) Burge PS, Calverley PMA, Jones PW, et al. Prednisolone response in patients with chronic obstructive pulmonary disease: results from the
ISOLDE study. Thorax 2003;58:654–8.
(2) Calverley PMA, Burge PS, Spencer A, et al. Bronchodilator reversibility
testing in chronic obstructive pulmonary disease. Thorax 2003;58:659–64.
(3) Chavannes NH, Schermer TRJ, Wouters EF, Van Weel C, Van Schayck CP.
Treatment of COPD in general practice: the COOPT study. Eur Respir J
2001;18(Suppl 33):348S.
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism
It is indeed unsatisfactory to make such recommendations in the
absence of prospective studies; three have now been published.[1-3]
Although differing in the way clinical probability was evaluated and in
the D-dimer assays used, all found that in combination many patients with
suspected pulmonary embo...
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism
It is indeed unsatisfactory to make such recommendations in the
absence of prospective studies; three have now been published.[1-3]
Although differing in the way clinical probability was evaluated and in
the D-dimer assays used, all found that in combination many patients with
suspected pulmonary embolism (PE) could safely be managed without further
imaging or anticoagulation. These encouraging results suggest that the
same is true with our simpler clinical model, originally conceived by
extrapolation from the deep vein thrombosis study of Wells’s group and
subsequently corroborated by them for PE.[4,5] A multi-centre study of
patients seen by middle-grade doctors in district general hospitals is
certainly very desirable.
A similar dilemma occurs in suspected subarachnoid haemorrhage (SAH),
another potentially fatal condition with a wide differential diagnosis.
Perhaps here too all should have an urgent CT scan, but in practice
clinicians use clinical pointers to decide when this is unnecessary.
Therefore, when updating our guidelines for PE (far commoner than SAH), we
decided to continue with a promising (albeit unproven) suggestion because
the two alternatives were less satisfactory. The first is that clinicians
continue to make decisions based on either no or inadequate imaging, which
should now be considered indefensible both medically and legally. The
second is that all patients with suspected pulmonary embolism should
undergo appropriate imaging, with major resource implications in a
situation where the diagnosis will only be confirmed in 15-30% of cases.
Although not yet irrefutable, evidence is growing that being selective in
requesting such tests is possible and safe.
References
(1) M Rodger, Wells P, Makropoulos D, et al. The bedside investigation
of pulmonary embolism diagnosis (BIOPED) study. Acad Emerg Med 2003;10:502.
(2) MG Leclercq, Lutisan JG, van Marwijk Kooy M, et al. Ruling out
clinically suspected pulmonary embolism by assessment of clinical
probability and D-dimer levels: a management study. Thromb Haemost 2003;89:97-103.
(3) JA Kline, Webb WB, Jones AE, et al. Impact of a clinical decision rule
and a D-dimer plus alveolar deadspace measurement to rule out pulmonary
embolism in an urban emergency department. Acad Emerg Med 2003;10:502.
(4) P Wells, Hirsh J, Anderson D, et al. Accuracy of clinical assessment of
deep-vein thrombosis. Lancet 1995;345:1326-30.
(5) PS Wells, Ginsberg JS, Anderson DR, et al. Use of a clinical model for
safe management of patients with suspected pulmonary embolism. Ann Intern
Med 1998;129:997-1005.
Dear Editor
Dr Latour-Perez's concerns[1] are anticipated on page 474 of our article, which summarises the results of three good quality studies using CTPA (not multi-slice) as the only imaging modality (references 187-189). Just after going to press we became aware of a recent excellent large multicentre study [2] with similar results. Combining these four of similar design (well conducted, CTPA only, no anticoagul...
Dear Editor
I would like to express my concern about the recent British Thoracic Society guidelines for the management of suspected acute pulmonary embolism,[1] which suggest that “Patients with a good quality negative CTPA do not require further investigation or treatment for PE.” [grade A recommendation]:
1. According to a recent well designed study,[2] the negative likelihood ratio of CTPA f...
Dear Editor
We thank Dr Chan for his comments relating to the recently published guidelines for the diagnosis and management of spontaneous pneumothorces.[1] Dr Chan raises the contentious issue of estimation of the size of a pneumothorax from a plain chest radiograph. We have attempted to use a variation of the method of Axel based on the largest distance from the chest wall to the pleural line and using the assum...
Dear Editor
"It is not the strongest of the species that survives, nor the most intelligent, it is the one most adaptable to change."
Charles Darwin (1809-1882)
The article "BTS guidelines for the management of spontaneous pneumothorax" by Henry et al.[1] has recently stimulated some discussion among our respiratory physicians and thoracic surgeons.
We found it in...
Dear Editor
The BTS guideline on chest drain management unfortunately fails to recognise the severity of illness of patients who generally require chest drain insertion on an intensive care unit. In our practice chest drainage for pleural effusions only occurs in ventilated patients who require more than 5cm H20 PEEP and still have significantly impaired oxygenation limiting their ability to be weaned fr...
Dear Editor
The negative findings of Joos et al. can be explained by the small signal for bronchodilator reversibility,such that one would not expect to detect any putative differences in beta-agonist response between genotypes ,as compared to asthma where the signal is much bigger. With repect to bronchial hyperresponsiveness (BHR), we have previously shown in asthmatics ,that the glycine genotype is associ...
Dear Editor
I read with interest the latest comprehensive BTS guidelines on chest drain insertion. We would like to share with you some tips and words of caution accumulated by experience from our institute.
During chest drain insertion, we routinely monitor oxygen saturation continuously with or without prior sedation. Patient with secondary pneumothorax i.e. from COAD can deteriorate during chest drai...
Dear Editor
I read, with interest, the new BTS guidelines for the management of spontaneous pneumothorax.[1] Arnold and colleagues acknowledged that the plain radiograph was a poor method of quantifying the size of a pneumothorax, yet then went on to use one radiographic method of assessment to estimate the degree of lung collapse.
Under the new guidelines, the size of a pneumothorax is divided into "...
Dear Editor
These clinically important papers [1,2] by the Isolde researchers provide excellent data questioning the rationale behind inclusion of patients in the large COPD-studies that have been reported in past few years. Selection of patients on the basis of absence of reversibility means ruling out the easiest measurable variable that may correlate with steroid response. When assessing effects of two weeks pred...
Dear Editor
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism
It is indeed unsatisfactory to make such recommendations in the absence of prospective studies; three have now been published.[1-3] Although differing in the way clinical probability was evaluated and in the D-dimer assays used, all found that in combination many patients with suspected pulmonary embo...
Pages